ReviewFrontiers in immunology2026

Beyond the chimeric antigen receptor T cells and bispecific antibody duopoly: ex vivo armed T cells for solid tumors.

Jeong A Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.